Ardelyx (ARDX) Cash from Operations (2013 - 2026)
Ardelyx (ARDX) reported Cash from Operations of 32237000.0 for Q1 2026, up 16.17% on a YoY basis from 27748915.75 in Q1 2025, and down 253.87% quarter-over-quarter from 20951000.0 in Q4 2025.
Ardelyx (ARDX) Cash from Operations (2013 - 2026) Analysis & Trends
Ardelyx has reported Cash from Operations for 14 years, with the latest figure at 32237000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 16.17% year-over-year to 32237000.0; the trailing twelve-month figure through Mar 2026 stood at 36263000.0 (up 23.73% YoY), and the FY2025 full-year result was 42483000.0, up 5.19% from the prior year.
- Cash from Operations for Q1 2026 stood at 32237000.0, down from 20951000.0 in the prior quarter.
- The five-year high for Cash from Operations was 20951000.0 in Q4 2025, with the low at 44795000.0 in Q1 2023.
- Historically, Cash from Operations has averaged 16428823.53 across 5 years, with a median of 21467000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Operations slumped 161.03% — and 2024, when it jumped 212.53%.
- Ardelyx's Cash from Operations stood at 14284000.0 in 2022, then slumped by 161.03% to 8718000.0 in 2023, then jumped by 212.53% to 9810000.0 in 2024, then jumped by 113.57% to 20951000.0 in 2025, then sank by 253.87% to 32237000.0 in 2026.
- The last three Cash from Operations figures came in at 32237000.0 (Q1 2026), 20951000.0 (Q4 2025), and 365000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -32.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.24 Mn |
| Mar 31, 2026 | -32.24 Mn |
| Dec 31, 2025 | 20.95 Mn |
| Dec 31, 2025 | 20.95 Mn |
| Sep 30, 2025 | 365,000.00 |
| Sep 30, 2025 | 365,000.00 |
| Jun 30, 2025 | -25.34 Mn |
| Jun 30, 2025 | -25.34 Mn |
| Mar 31, 2025 | -38.46 Mn |
| Mar 31, 2025 | -38.46 Mn |
| Dec 31, 2024 | 9.81 Mn |
| Dec 31, 2024 | 9.81 Mn |
| Sep 30, 2024 | 501,000.00 |
| Sep 30, 2024 | 501,000.00 |
| Jun 30, 2024 | -19.40 Mn |
| Jun 30, 2024 | -19.40 Mn |
| Mar 31, 2024 | -35.72 Mn |
| Mar 31, 2024 | -35.72 Mn |
| Dec 31, 2023 | -8.72 Mn |
| Dec 31, 2023 | -8.72 Mn |